Treatment generally consists of subfrontal or transsphenoidal excision. Endoscopic surgery through the nose often performed by a joint team of neurosurgeons and ENT, is increasingly being considered as an alternative to transcranial surgery done by making an opening in the skull. Because of the location of the<unk>  near the brain and skullbase, a surgical navigation system might be used to verify the position of surgical tools during the operation. Additional radiotherapy is also used if total removal is not possible. Due to the poor outcomes associated with damage to the pituitary and hypothalamus from surgical removal and radiation, experimental therapies using intracavitary phosphorus-32, yttrium, or bleomycin delivered via an external reservoir are sometimes employed, especially in young patients. The tumor, being in the pituitary gland, can cause secondary health problems. The immune system, thyroid levels, growth hormone levels, and testosterone levels can be compromised from<unk> . All of these health problems can be treated with modern medicine. No high quality evidence has evaluated the use of bleomycin in this condition. Proton therapy affords a reduction in dose to critical structures compared to conventional photon radiation, including IMRT, for patients with<unk> . The most effective treatment 'package' for the malignant<unk> s described in literature is a combination 'gross total resective' surgery with adjuvant chemoradiotherapy. The chemotherapy drugs paclitaxel and carboplatin have shown a clinical (but not statistical) significance in increasing the survival rate in patients who have had gross total resections of their malignant tumours.
Craniopharyngioma
Subependymoma
Glial tumor
Vestibular schwannoma
Mantleoma
Central neurocytoma
Choroid plexus papilloma
Germinoma